FDA Inspection 1307874 — KP Pharmaceutical Technology
The FDA completed an inspection of KP Pharmaceutical Technology on February 13, 2026 in Bloomington, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 13, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bloomington, IN (United States)